Millrace Asset Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-15,690
Closed -$933K 84
2020
Q3
$933K Sell
15,690
-8,762
-36% -$521K 0.75% 64
2020
Q2
$1.71M Buy
+24,452
New +$1.71M 1.74% 20
2019
Q3
Sell
-21,915
Closed -$1.56M 70
2019
Q2
$1.56M Sell
21,915
-6,939
-24% -$494K 1.61% 25
2019
Q1
$2.26M Buy
+28,854
New +$2.26M 1.91% 19